Jeehye Park

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Large-scale mapping of the MCH network in ALS mice reveals the vulnerability of dopaminergic and GABAergic neurons in zona incerta.

Large-scale mapping of the MCH network in ALS mice reveals the vulnerability of dopaminergic and GABAergic neurons in zona incerta.

Journal: Acta neuropathologica communications

Published: November 25, 2025

Protocol for autofluorescence removal in microglia by photobleaching in free-floating immunofluorescent staining of mouse brain tissue.

Protocol for autofluorescence removal in microglia by photobleaching in free-floating immunofluorescent staining of mouse brain tissue.

Journal: STAR protocols

Published: August 03, 2025

Interventionally targeting somatic CAG expansions can be a rapid disease-modifying therapeutic avenue: Preclinical evidence.

Interventionally targeting somatic CAG expansions can be a rapid disease-modifying therapeutic avenue: Preclinical evidence.

Journal: bioRxiv : the preprint server for biology

Published: May 07, 2025

MATR3's Role beyond the Nuclear Matrix: From Gene Regulation to Its Implications in Amyotrophic Lateral Sclerosis and Other Diseases.

MATR3's Role beyond the Nuclear Matrix: From Gene Regulation to Its Implications in Amyotrophic Lateral Sclerosis and Other Diseases.

Journal: Cells

Published: May 13, 2024

Knockout of Dectin-1 does not modify disease onset or progression in a MATR3 S85C knock-in mouse model of ALS.

Knockout of Dectin-1 does not modify disease onset or progression in a MATR3 S85C knock-in mouse model of ALS.

Journal: Heliyon

Published: May 10, 2024

MATR3 pathogenic variants differentially impair its cryptic splicing repression function.

MATR3 pathogenic variants differentially impair its cryptic splicing repression function.

Journal: FEBS letters

Published: December 06, 2023

Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential.

Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential.

Journal: Biology

Published: August 11, 2023

LONRF2 is a gatekeeper against protein aggregation in aging neurons.

LONRF2 is a gatekeeper against protein aggregation in aging neurons.

Journal: Nature aging

Published: July 20, 2023

Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models.

Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models.

Journal: Biomolecules

Published: April 21, 2023

Selective Loss of MATR3 in Spinal Interneurons, Upper Motor Neurons and Hippocampal CA1 Neurons in a MATR3 S85C Knock-In Mouse Model of Amyotrophic Lateral Sclerosis.

Selective Loss of MATR3 in Spinal Interneurons, Upper Motor Neurons and Hippocampal CA1 Neurons in a MATR3 S85C Knock-In Mouse Model of Amyotrophic Lateral Sclerosis.

Journal: Biology

Published: December 21, 2021

MATR3 F115C knock-in mice do not exhibit motor defects or neuropathological features of ALS.

MATR3 F115C knock-in mice do not exhibit motor defects or neuropathological features of ALS.

Journal: Biochemical and biophysical research communications

Published: May 10, 2021

Knockdown of genes involved in axonal transport enhances the toxicity of human neuromuscular disease-linked MATR3 mutations in Drosophila.

Knockdown of genes involved in axonal transport enhances the toxicity of human neuromuscular disease-linked MATR3 mutations in Drosophila.

Journal: FEBS letters

Published: May 18, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026